GlassScriptPhysician profile
Maria Alne
NPI 1275980336
$10,347.42
in general payments reported to CMS, 2019-2025
42 companies · $1,100 in 2025
The $1,100 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $1,653 · 2021: $1,245 · 2022: $1,369 · 2023: $2,233 · 2024: $2,156 · 2025: $1,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,489.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,496.48 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,167.15 | 2020-2025 | Vraylar, Ubrelvy, Botox |
| Amgen INC. | $941.29 | 2019-2025 | Repatha, Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $596.93 | 2019-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $573.32 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $564.48 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $462.44 | 2019-2025 | |
| Glaxosmithkline, LLC. | $417.86 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $389.16 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $263.65 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $257.16 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $246.78 | 2022-2025 | |
| Abbott Laboratories | $234.38 | 2022-2024 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $229.41 | 2019-2023 | Steglatro |
| Radius Health, INC. | $214.47 | 2020-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Alne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.